Roles of CNC Transcription Factors NRF1 and NRF2 in Cancer

Hiroki Sekine1, Hozumi Motohashi1

  • 1Department of Gene Expression Regulation, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan.

Cancers
|February 4, 2021
PubMed

Insights

Cancer cells exploit metabolism for survival. Transcription factors NRF2 and NRF1 promote cancer malignancy and drug resistance, respectively, through metabolic reprogramming and proteasome activity regulation.

Area of Science:

  • Cellular metabolism
  • Cancer biology
  • Molecular oncology

Background:

  • Cancer cells utilize unique metabolic pathways for survival and proliferation.
  • Nuclear factor erythroid 2-like 2 (NRF2) activation promotes cancer malignancy and therapeutic resistance via metabolic reprogramming.
  • Nuclear factor erythroid 1 (NRF1) contributes to cancer drug resistance by maintaining proteasome activity.

Purpose of the Study:

  • To review NRF2-mediated cancer malignancy.
  • To elaborate on NRF1-mediated drug resistance influenced by UDP-GlcNAc.

Main Methods:

  • Literature review focusing on NRF2 and NRF1 functions in cancer.
  • Analysis of metabolic reprogramming in cancer cells.
  • Examination of the role of UDP-GlcNAc in NRF1 activation.

Main Results:

  • NRF2 activation enhances cancer cell tumorigenesis and resistance.
  • NRF1 protects cancer cells from proteasome inhibitor toxicity.
  • UDP-GlcNAc, generated via the hexosamine pathway, activates NRF1.

Conclusions:

  • Cancer cell metabolic signatures are linked to CNC family member functions.
  • NRF2 and NRF1 play critical roles in cancer progression and therapeutic resistance.
  • Targeting NRF1 and UDP-GlcNAc metabolism may offer strategies for overcoming cancer drug resistance.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.4K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
8.7K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K